Published in Cell Immunol on October 01, 1995
Monitoring immune dysfunctions in the septic patient: a new skin for the old ceremony. Mol Med (2008) 2.93
NF-kappa B activation in airways modulates allergic inflammation but not hyperresponsiveness. J Immunol (2004) 1.73
Glucocorticoid-regulated genes in eosinophilic esophagitis: a role for FKBP51. J Allergy Clin Immunol (2010) 1.63
Involvement of CREB binding protein in expression of major histocompatibility complex class II genes via interaction with the class II transactivator. Mol Cell Biol (1998) 1.52
Putative biological mechanisms for the association between early life adversity and the subsequent development of PTSD. Psychopharmacology (Berl) (2010) 1.49
Interactions between the class II transactivator and CREB binding protein increase transcription of major histocompatibility complex class II genes. Mol Cell Biol (1999) 1.46
Expanded CD14+ CD16+ monocyte subpopulation in patients with acute and chronic infections undergoing hemodialysis. Infect Immun (1998) 1.24
A Review of GM-CSF Therapy in Sepsis. Medicine (Baltimore) (2015) 0.84
Traumatic Brain Injury and Peripheral Immune Suppression: Primer and Prospectus. Front Neurol (2015) 0.83
Epithelial cells as immune effector cells: the role of CD40. Semin Immunol (2009) 0.83
Primary immune response to keyhole limpet haemocyanin following trauma in relation to low plasma glutamine. Clin Exp Immunol (2004) 0.79
Postoperative immunosuppression markers and the occurrence of sepsis in patients with benign and malignant disease. Wien Klin Wochenschr (2014) 0.76
Dexamethasone Suppresses Oxysterol-Induced Differentiation of Monocytic Cells. Oxid Med Cell Longev (2016) 0.75
Cultured human vascular endothelial cells acquire adhesiveness for neutrophils after stimulation with interleukin 1, endotoxin, and tumor-promoting phorbol diesters. J Immunol (1986) 3.41
Adhesion of human basophils, eosinophils, and neutrophils to interleukin 1-activated human vascular endothelial cells: contributions of endothelial cell adhesion molecules. J Exp Med (1991) 2.76
Oncostatin M as a potent mitogen for AIDS-Kaposi's sarcoma-derived cells. Science (1992) 1.98
Filarial nematode parasites secrete a homologue of the human cytokine macrophage migration inhibitory factor. Infect Immun (1998) 1.87
Activation of eotaxin gene transcription by NF-kappa B and STAT6 in human airway epithelial cells. J Immunol (1999) 1.83
Human lung mast cells: purification and characterization. J Immunol (1982) 1.78
Generation of leukotrienes by purified human lung mast cells. J Clin Invest (1982) 1.77
Studies on the adhesive interaction between purified human eosinophils and cultured vascular endothelial cells. J Immunol (1988) 1.68
IL-13 selectively induces vascular cell adhesion molecule-1 expression in human endothelial cells. J Immunol (1995) 1.68
Inhibition of cytokine generation and mediator release by human basophils treated with desloratadine. Clin Exp Allergy (2001) 1.63
Transgenic mice expressing a truncated form of the high mobility group I-C protein develop adiposity and an abnormally high prevalence of lipomas. J Biol Chem (2000) 1.57
Atopic dermatitis is associated with a functional mutation in the promoter of the C-C chemokine RANTES. J Immunol (2000) 1.52
Arachidonic acid metabolism in purified human lung mast cells. J Immunol (1984) 1.47
Identification of SAF-2, a novel siglec expressed on eosinophils, mast cells, and basophils. J Allergy Clin Immunol (2000) 1.46
Episodic eosinophilia-myalgia-like syndrome in a patient without L-tryptophan use: association with eosinophil activation and increased serum levels of granulocyte-macrophage colony-stimulating factor. J Allergy Clin Immunol (1991) 1.45
Secretion of IL-4 from human basophils. The relationship between IL-4 mRNA and protein in resting and stimulated basophils. J Immunol (1994) 1.44
Interleukin-13 upregulates eotaxin expression in airway epithelial cells by a STAT6-dependent mechanism. Am J Respir Cell Mol Biol (2001) 1.42
Eosinophils in health and disease: the LIAR hypothesis. Clin Exp Allergy (2010) 1.41
Effects of dexamethasone on mediator release from human lung fragments and purified human lung mast cells. J Clin Invest (1983) 1.41
Eosinophil transendothelial migration induced by cytokines. III. Effect of the chemokine RANTES. J Immunol (1994) 1.38
Eosinophil transendothelial migration induced by cytokines. I. Role of endothelial and eosinophil adhesion molecules in IL-1 beta-induced transendothelial migration. J Immunol (1992) 1.38
Heterogeneity of human mast cells. J Immunol (1983) 1.37
Expression of the chemokine RANTES by a human bronchial epithelial cell line. Modulation by cytokines and glucocorticoids. J Immunol (1995) 1.33
Recombinant IL-3 induces histamine release from human basophils. J Immunol (1989) 1.31
Induction of apoptosis in human eosinophils by anti-Fas antibody treatment in vitro. Blood (1995) 1.30
How are class II MHC genes turned on and off? FASEB J (1995) 1.24
Oncostatin-M is an autocrine growth factor in Kaposi's sarcoma. Am J Pathol (1994) 1.23
Production of the novel C-C chemokine MCP-4 by airway cells and comparison of its biological activity to other C-C chemokines. J Clin Invest (1997) 1.22
Glucocorticoids inhibit eosinophil responses to granulocyte-macrophage colony-stimulating factor. J Immunol (1991) 1.21
Chemokines and allergic disease. J Allergy Clin Immunol (1999) 1.20
Nonrandom association of cellular antigens with HTLV-III virions. Hum Immunol (1987) 1.20
Reduced expression of antimicrobial PLUNC proteins in nasal polyp tissues of patients with chronic rhinosinusitis. Allergy (2012) 1.18
Cutaneous injection of human subjects with macrophage inflammatory protein-1 alpha induces significant recruitment of neutrophils and monocytes. J Immunol (2000) 1.16
Increased levels of interleukin-1 are detected in nasal secretions of volunteers during experimental rhinovirus colds. J Infect Dis (1994) 1.15
Dispersed human lung mast cells. Pharmacologic aspects and comparison with human lung tissue fragments. Am Rev Respir Dis (1982) 1.14
Differential regulation of epithelial-derived C-C chemokine expression by IL-4 and the glucocorticoid budesonide. J Immunol (1999) 1.14
Production of granulocyte-macrophage colony-stimulating factor by cultured human tracheal epithelial cells. Immunology (1992) 1.14
Inhibition of basophil histamine release by anti-inflammatory steroids. Nature (1981) 1.14
Polymorphic nucleotides within the human IL-4 promoter that mediate overexpression of the gene. J Immunol (1996) 1.13
The role of adhesion molecules in human eosinophil and basophil recruitment. J Allergy Clin Immunol (1994) 1.12
Cloning and functional characterization of a novel human CC chemokine that binds to the CCR3 receptor and activates human eosinophils. J Leukoc Biol (1997) 1.12
Purification and identification of brain-derived neurotrophic factor from human serum. Protein Expr Purif (1995) 1.11
Regulation of human basophil and lung mast cell function by cyclic adenosine monophosphate. J Immunol (1988) 1.11
Comparative studies of human basophils and mast cells. Fed Proc (1983) 1.11
Ultrastructural immunogold localization of prostaglandin endoperoxide synthase (cyclooxygenase) to non-membrane-bound cytoplasmic lipid bodies in human lung mast cells, alveolar macrophages, type II pneumocytes, and neutrophils. J Histochem Cytochem (1992) 1.10
Mast cells, basophils, and eosinophils: distinct but overlapping pathways for recruitment. Immunol Rev (2001) 1.10
Lipopolysaccharide-induced leukocyte rolling and adhesion in the rat mesenteric microcirculation: regulation by glucocorticoids and role of cytokines. J Immunol (1998) 1.09
Eosinophil transendothelial migration induced by cytokines. II. Potentiation of eosinophil transendothelial migration by eosinophil-active cytokines. J Immunol (1994) 1.07
Differences in the behavior of cytoplasmic granules and lipid bodies during human lung mast cell degranulation. J Cell Biol (1984) 1.07
CD44 and CD69 represent different types of cell-surface activation markers for human eosinophils. Am J Respir Cell Mol Biol (1998) 1.06
Human lung macrophage-derived histamine-releasing activity is due to IgE-dependent factors. J Immunol (1986) 1.05
Detection of the chemokine RANTES and endothelial adhesion molecules in nasal polyps. J Allergy Clin Immunol (1996) 1.05
Interaction between hyperosmolar and IgE-mediated histamine release from basophils and mast cells. Am Rev Respir Dis (1984) 1.05
Phenotyping and cytokine regulation of the BEAS-2B human bronchial epithelial cell: demonstration of inducible expression of the adhesion molecules VCAM-1 and ICAM-1. Am J Respir Cell Mol Biol (1997) 1.03
Functional roles of the transcription factor Oct-2A and the high mobility group protein I/Y in HLA-DRA gene expression. J Exp Med (1995) 1.03
Structural requirements for recognition of the HLA-Dw14 class II epitope: a key HLA determinant associated with rheumatoid arthritis. Proc Natl Acad Sci U S A (1990) 1.03
Role of human basophils and mast cells in the pathogenesis of allergic diseases. J Allergy Clin Immunol (1985) 1.02
Characterization of inflammatory mediator release from purified human lung mast cells. Am Rev Respir Dis (1986) 1.01
Class II molecules of the major histocompatibility complex considered as differentiation markers. Hum Immunol (1986) 1.01
Prednisone inhibits the appearance of inflammatory mediators and the influx of eosinophils and basophils associated with the cutaneous late-phase response to allergen. J Immunol (1991) 1.01
Effects of prednisone on the cellular responses and release of cytokines and mediators after segmental allergen challenge of asthmatic subjects. J Allergy Clin Immunol (2001) 1.00
SFR3-DR5, a monoclonal antibody with HLA-DR5 specificity. J Immunol (1983) 1.00
Flow cytometric methods for the analysis of human basophil surface antigens and viability. J Immunol Methods (1989) 1.00
Analysis of monoclonal antibodies reactive with human class II beta chains by two-dimensional electrophoresis and Western blotting. Hum Immunol (1984) 1.00
Identification and characterization of a critical CP2-binding element in the human interleukin-4 promoter. J Biol Chem (2000) 0.99
A monoclonal antibody directed against the HLA-Bw6 epitope. J Immunol (1982) 0.99
Glucocorticosteroid inhibition of cytokine production: relevance to antiallergic actions. J Allergy Clin Immunol (1996) 0.99
Inhibition of basophil histamine release by anti-inflammatory steroids. II. Studies on the mechanism of action. J Immunol (1982) 0.98
Human lung macrophages enhance and inhibit lymphocyte proliferation. J Immunol (1984) 0.98
Interleukin-1 is released at sites of human cutaneous allergic reactions. J Allergy Clin Immunol (1990) 0.98
Differential synthesis of 1-acyl-2-acetyl-sn-glycero-3-phosphocholine and platelet-activating factor by human inflammatory cells. J Immunol (1991) 0.97
Double-stranded RNA activates RANTES gene transcription through co-operation of nuclear factor-kappaB and interferon regulatory factors in human airway epithelial cells. Clin Exp Allergy (2004) 0.96
Inhibition of NF-AT-dependent transcription by NF-kappa B: implications for differential gene expression in T helper cell subsets. Proc Natl Acad Sci U S A (1995) 0.96
Adherence of human basophils to cultured umbilical vein endothelial cells. J Clin Invest (1988) 0.96
Effect of short-term systemic glucocorticoid treatment on human nasal mediator release after antigen challenge. J Clin Invest (1987) 0.95
Preliminary identification and role of phosphodiesterase isozymes in human basophils. J Immunol (1992) 0.95
Inhibition of T cell-mediated cytotoxicity by anti-inflammatory steroids. J Immunol (1984) 0.95
Release of histamine from human leukocytes stimulated with the tumor-promoting phorbol diesters. I. Characterization of the response. J Immunol (1981) 0.95
Interleukin 1 production by human lung tissue. II. Inhibition by anti-inflammatory steroids. J Immunol (1987) 0.94
Expression of a functional laminin receptor (alpha 6 beta 1, very late activation antigen-6) on human eosinophils. Blood (1993) 0.94
Retinal transplantation: progress and problems in clinical application. J Leukoc Biol (2003) 0.94
Variation in dinucleotide (GT) repeat sequence in the first exon of the STAT6 gene is associated with atopic asthma and differentially regulates the promoter activity in vitro. J Med Genet (2004) 0.94
Dexamethasone does not inhibit the release of mediators from human mast cells residing in airway, intestine, or skin. Am Rev Respir Dis (1989) 0.94
Increased local IgE production induced by common aeroallergens and phenotypic alteration of mast cells in Chinese eosinophilic, but not non-eosinophilic, chronic rhinosinusitis with nasal polyps. Clin Exp Allergy (2014) 0.93
Functional domains of the cone-rod homeobox (CRX) transcription factor. J Biol Chem (2000) 0.93
Differential regulation of human basophil and lung mast cell function by adenosine. J Pharmacol Exp Ther (1991) 0.93
Inhibition of VCAM-1 expression in human bronchial epithelial cells by glucocorticoids. Am J Respir Cell Mol Biol (1999) 0.93
Qualitative differences between dimeric and trimeric stimulation of human basophils. J Immunol (1983) 0.93
The mechanisms of antiinflammatory steroid action in allergic diseases. Annu Rev Pharmacol Toxicol (1985) 0.92
Immunoglobulin E-mediated degranulation of isolated human lung mast cells. Lab Invest (1985) 0.91
IL-3 augments adhesiveness for endothelium and CD11b expression in human basophils but not neutrophils. J Immunol (1990) 0.91
Elevated presence of myeloid dendritic cells in nasal polyps of patients with chronic rhinosinusitis. Clin Exp Allergy (2015) 0.90
Pathogenesis of nasal polyposis. Clin Exp Allergy (2015) 0.90
Human endothelial cells prolong eosinophil survival. Regulation by cytokines and glucocorticoids. J Immunol (1989) 0.90
The architectural transcription factor high mobility group I(Y) participates in photoreceptor-specific gene expression. J Neurosci (2000) 0.89
Immunologic and genetic studies of diabetes in the BB rat. Crit Rev Immunol (1989) 0.89
Human mast cells use conservation and condensation mechanisms during recovery from degranulation. In vitro studies with mast cells purified from human lungs. Lab Invest (1986) 0.89
Selective glucocorticoid receptor translational isoforms reveal glucocorticoid-induced apoptotic transcriptomes. Cell Death Dis (2013) 0.89